|
Volume 272, Number 28,
Issue of July 11, 1997
pp. 17719-17725
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Amidophosphoribosyltransferase Limits the Rate of Cell
Growth-linked de Novo Purine Biosynthesis in the
Presence of Constant Capacity of Salvage Purine Biosynthesis
(Received for publication, April 3, 1997)
Takashi
Yamaoka
,
Maki
Kondo
,
Soichi
Honda
,
Hiroyuki
Iwahana
,
Maki
Moritani
,
Setsuko
Ii
,
Katsuhiko
Yoshimoto
and
Mitsuo
Itakura
From the Otsuka Department of Clinical and Molecular Nutrition,
School of Medicine, The University of Tokushima, 3-18-15, Kuramoto-cho, Tokushima-city, 770, Japan
Factors controlling relative flux rates of the
de novo and salvage pathways of purine nucleotide
biosynthesis during animal cell growth are not fully understood. To
examine the relative role of each pathway for cell growth, three cell
lines including CHO K1 (a wild-type Chinese hamster ovary fibroblast
cell line), CHO ade A (an auxotrophic cell line deficient
of amidophosphoribosyltransferase (ATase), a presumed rate-limiting
enzyme of the de novo pathway), and CHO ade A
transfected with human ATase cDNA ( A+hATase)
resulting in 30-350% of the ATase activity of CHO K1, were cultured
in purine-rich or purine-free media. Based on the enzyme activities of
ATase and hypoxanthine phosphoribosyltransferase, the metabolic rate of
the de novo and salvage pathways, the rate of cell growth
(growth rate) in three cell lines under various culture conditions, and
the effect of hypoxanthine infusion on the metabolic rate of the
de novo pathway in rat liver, we concluded the following.
1) In A+hATase transfectants, ATase activity limits the
rate of the de novo pathway, which is closely linked with
the growth rate. 2) Purine nucleotides are synthesized preferentially
by the salvage pathway as long as hypoxanthine, the most essential
source of purine salvage, can be utilized, which was confirmed in rat
liver in vivo by hypoxanthine infusion. The preferential
usage of the salvage pathway results in sparing the energy expenditure
required for de novo synthesis. 3) The regulatory capacity
of the de novo pathway (about 200%) was larger than that
of the salvage pathway (about 20%) with constant hypoxanthine
phosphoribosyltransferase activity.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. An, R. Kumar, E. D. Sheets, and S. J. Benkovic
Reversible Compartmentalization of de Novo Purine Biosynthetic Complexes in Living Cells
Science,
April 4, 2008;
320(5872):
103 - 106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Malmanche and D. V. Clark
Identification of Trans-dominant Modifiers of Prat Expression in Drosophila melanogaster
Genetics,
August 1, 2003;
164(4):
1419 - 1433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Brault and R. L. Terjung
Purine salvage to adenine nucleotides in different skeletal muscle fiber types
J Appl Physiol,
July 1, 2001;
91(1):
231 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yamaoka, M. Yano, M. Kondo, H. Sasaki, S. Hino, R. Katashima, M. Moritani, and M. Itakura
Feedback Inhibition of Amidophosphoribosyltransferase Regulates the Rate of Cell Growth via Purine Nucleotide, DNA, and Protein Syntheses
J. Biol. Chem.,
June 8, 2001;
276(24):
21285 - 21291.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|